Popular e-cigarette Juul comes under attack
BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l4249 (Published 18 June 2019) Cite this as: BMJ 2019;365:l4249- Douglas Kamerow, senior scholar, Robert Graham Center for policy studies in primary care, professor of family medicine at Georgetown University, and associate editor, The BMJ
- dkamerow{at}aafp.org
Juul, the wildly popular e-cigarette the size of a flash drive, continues to grow in market share and controversy in the US. Its easy concealability, fruit flavors, and youthful social media models attracted a large teenage following. The highly addictive nicotine-salt formula has kept them coming back for more.1
Introduced in 2015, Juul is now estimated to control 70% of the US market. It has left other brands (many owned by tobacco companies) in the dust. Altria, the US arm of Phillip Morris, for example, brought out its own e-cigarette brand, Mark Ten, in 2014, but sales were meager despite high expectations. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.